Autonomous Healthcare Wins $1.9M NIH Grant to Streamline Pharmacy Workflows
Summary
HOBOKEN, N.J., Oct. 16, 2023 /PRNewswire/ -- Autonomous Healthcare, a medical technology company pioneering the use of automation in clinical care workflows, announced that it received a $1.9M Phase II Small Business Innovation Research (SBIR) grant by the National Institute on Drug Abuse of the National Institutes of Health (NIH) to further advance and commercialize its innovative TraCS drug management platform. "Introducing advanced AI and automation in the pharmacy will have a direct impact on patient safety and clinical workflow efficiency," said Behnood Gholami, PhD, CEO of Autonomous Healthcare. "ASC operators deliver patient care under unique circumstances versus hospital surgical facilities, and this leads to specialized needs to optimize costs and administrative burden, and improve patient safety," said James M. Bailey, MD, PhD, Chief Medical Officer of Autonomous Healthcare. "This funding will support further development and deployment of the TraCS platform, which leverages recent advances in AI and blockchain technology, to provide pharmacies with a digital solution to streamline their workflow and detect drug diversion related to controlled substances in real time.Autonomous Healthcare is pioneering the development of the next generation of AI-based technologies for healthcare with the ultimate goal of reducing morbidity and mortality by introducing various levels of automation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.